Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 7
1956 6
1957 4
1958 1
1959 3
1960 3
1961 1
2006 1
2010 2
2011 2
2013 5
2014 2
2015 2
2016 4
2017 5
2018 4
2019 3
2020 12
2021 10
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

70 results
Results by year
Filters applied: . Clear all
Page 1
Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non-Small Cell Lung Cancer.
Khorrami M, Prasanna P, Gupta A, Patil P, Velu PD, Thawani R, Corredor G, Alilou M, Bera K, Fu P, Feldman M, Velcheti V, Madabhushi A. Khorrami M, et al. Among authors: velu pd. Cancer Immunol Res. 2020 Jan;8(1):108-119. doi: 10.1158/2326-6066.CIR-19-0476. Epub 2019 Nov 12. Cancer Immunol Res. 2020. PMID: 31719058 Free PMC article.
Clinical Performance of SARS-CoV-2 Molecular Tests.
Green DA, Zucker J, Westblade LF, Whittier S, Rennert H, Velu P, Craney A, Cushing M, Liu D, Sobieszczyk ME, Boehme AK, Sepulveda JL. Green DA, et al. Among authors: velu p. J Clin Microbiol. 2020 Jul 23;58(8):e00995-20. doi: 10.1128/JCM.00995-20. Print 2020 Jul 23. J Clin Microbiol. 2020. PMID: 32513858 Free PMC article.
CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in Stage I, II resectable Non-Small Cell Lung Cancer: a retrospective multi-cohort study for outcome prediction.
Vaidya P, Bera K, Gupta A, Wang X, Corredor G, Fu P, Beig N, Prasanna P, Patil P, Velu P, Rajiah P, Gilkeson R, Feldman M, Choi H, Velcheti V, Madabhushi A. Vaidya P, et al. Among authors: velu p. Lancet Digit Health. 2020 Mar;2(3):e116-e128. doi: 10.1016/s2589-7500(20)30002-9. Epub 2020 Feb 13. Lancet Digit Health. 2020. PMID: 32123864 Free PMC article.
Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States.
Alpert T, Brito AF, Lasek-Nesselquist E, Rothman J, Valesano AL, MacKay MJ, Petrone ME, Breban MI, Watkins AE, Vogels CBF, Kalinich CC, Dellicour S, Russell A, Kelly JP, Shudt M, Plitnick J, Schneider E, Fitzsimmons WJ, Khullar G, Metti J, Dudley JT, Nash M, Beaubier N, Wang J, Liu C, Hui P, Muyombwe A, Downing R, Razeq J, Bart SM, Grills A, Morrison SM, Murphy S, Neal C, Laszlo E, Rennert H, Cushing M, Westblade L, Velu P, Craney A, Cong L, Peaper DR, Landry ML, Cook PW, Fauver JR, Mason CE, Lauring AS, St George K, MacCannell DR, Grubaugh ND. Alpert T, et al. Among authors: velu p. Cell. 2021 May 13;184(10):2595-2604.e13. doi: 10.1016/j.cell.2021.03.061. Epub 2021 Apr 3. Cell. 2021. PMID: 33891875 Free PMC article.
Classes of ITD Predict Outcomes in AML Patients Treated with FLT3 Inhibitors.
Schwartz GW, Manning B, Zhou Y, Velu P, Bigdeli A, Astles R, Lehman AW, Morrissette JJD, Perl AE, Li M, Carroll M, Faryabi RB. Schwartz GW, et al. Among authors: velu p. Clin Cancer Res. 2019 Jan 15;25(2):573-583. doi: 10.1158/1078-0432.CCR-18-0655. Epub 2018 Sep 4. Clin Cancer Res. 2019. PMID: 30181385 Free PMC article.
Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study.
Khorrami M, Bera K, Leo P, Vaidya P, Patil P, Thawani R, Velu P, Rajiah P, Alilou M, Choi H, Feldman MD, Gilkeson RC, Linden P, Fu P, Pass H, Velcheti V, Madabhushi A. Khorrami M, et al. Among authors: velu p. Lung Cancer. 2020 Apr;142:90-97. doi: 10.1016/j.lungcan.2020.02.018. Epub 2020 Feb 26. Lung Cancer. 2020. PMID: 32120229 Free PMC article.
70 results